Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma
Author:
Affiliation:
1. University of California, Irvine Medical Center, Orange, CA, USA
Funder
National Cancer Institute T32 Training Grant
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425255.2016.1216976
Reference47 articles.
1. Skin cancers: how common is skin cancer? Ultraviolet radiation and the INTERSUN Programme. Geneva: World Health Organization. [cited 2016 Apr 5]. Available from: http://www.who.int/uv/faq/skincancer/en/index1.html
2. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
3. Melanoma as a model tumour for immuno-oncology
4. Immunity against cancer: lessons learned from melanoma
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative Analytical Evaluation of the Proposed Biosimilar FYB206 and its Reference Medicinal Product Keytruda®;Drugs in R&D;2024-09-04
2. Application of newly developed and validated LC-MS/MS method for pharmacokinetic study of adagrasib and pembrolizumab simultaneously in rat plasma;Journal of Chromatography B;2024-07
3. Transforming cancer care: Immunotherapy with advanced drug delivery;Journal of Drug Delivery Science and Technology;2024-06
4. Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective;Pharmaceuticals;2024-04-20
5. Immunogenic cell death induced by low temperature plasma to activate antitumor immunity and enhance therapeutic efficiency;Journal of Physics D: Applied Physics;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3